Genetic analysis of mucopolysaccharidosis type VI in Taiwanese patients

Clinica Chimica Acta

Volumn 394, Issue 1-2, 2008, Pages 89-93

  Lin, Wei De ^a,b   Lin, Shuan Pei ^c   Wang, Chung Hsing ^a   Hwu, Wuh Liang ^d   Chuang, Chih Kuang ^c,g   Lin, Shio Jean ^e   Tsai, Yushin ^b   Chen, Chih Ping ^c   Tsai, Fuu Jen ^a,b,f  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^f ASIA UNIVERSITY   (Taiwan)

^g FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Arylsulfatase B; Gene mutation; Lysosomal diseases; Maroteaux Lamy syndrome; Mucopolysaccharidosis type VI

Indexed keywords

DERMATAN SULFATE; GLYCOSAMINOGLYCAN; N ACETYLGALACTOSAMINE 4 SULFATASE;

ADOLESCENT; ADULT; ARSB GENE; ARTICLE; CHILD; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; GENE; GENE ACTIVITY; GENE MUTATION; GENETIC ANALYSIS; HUMAN; LEUKOCYTE; MALE; MISSENSE MUTATION; MORQUIO SYNDROME; PREVALENCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TWO DIMENSIONAL ELECTROPHORESIS; URINALYSIS; VALIDATION PROCESS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MUCOPOLYSACCHARIDOSIS VI; MUTATION; TAIWAN;

EID: 44649175624     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.04.014     Document Type: Article

References (32)

1. Neufeld E.F., and Muenzer J. The mucopolysaccharidoses. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The metabolic and molecular basis of inherited disease (2001), Mc-Graw-Hill, New York 3421-3452
2. Brooks D.A., Gibson G.J., Karageorgos L., Hein L.K., Robertson E.F., and Hopwood J.J. An index case for the attenuated end of the mucopolysaccharidosis type VI clinical spectrum. Mol Genet Metab 85 (2005) 236-238
3. Quigley H.A., and Kenyon K.R. Ultrastructural and histochemical studies of a newly recognized form of systemic mucopolysaccharidosis. (Maroteaux-Lamy syndrome, mild phenotype). Am J Ophthalmol 77 (1974) 809-818
4. Wald S.L., and Schmidek H.H. Compressive myelopathy associated with type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome). Neurosurgery 14 (1984) 83-88
5. Krivit W. Stem cell bone-marrow transplantation in patients with metabolic storage diseases. Adv Pediatr 49 (2002) 359-378
6. Herskhovitz E., Young E., Rainer J., et al. Bone-marrow transplantation for Maroteaux-Lamy syndrome (MPS VI): long term follow up. J Inherit Metab Dis 22 (1999) 50-62
7. Harmatz P., Whitley C.B., Waber L., et al. Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). J Pediatr 144 (2004) 574-580
8. Harmatz P., Giugliani R., Schwartz I., et al. Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or RHASB) and follow-on open-label extension study. J Pediatr 148 (2006) 533-539
9. Peters C., Schmidt B., Rommerskirch W., et al. Phylogenetic conservation of arylsulfatases: cDNA cloning and expression of human arylsulfatase B. J Biol Chem 265 (1990) 3374-3381
10. Schuchman E.H., Jackson C.E., and Desnick R.J. Human arylsulfatase B: MOPAC cloning, nucleotide sequence of a full-length cDNA, and regions of amino acid identity with arylsulfatase A and C. Genomics 6 (1990) 149-158
11. Fidzianskav E., Abramowicz T., Czartoryska B., et al. Further steps in regional localization of the gene coding for human arylsulfatase B (ARSB): gene assignment to the section q11-qter of chromosome 5. Probl Med Wieku Rozwoj 16 (1990) 163-165
12. Modaressi S., Rupp K., von Figura K., and Peters C. Structure of the human arylsulfatase B gene. Biol Chem Hoppe Seyler 374 (1993) 327-335
13. Bond C.S., Clements P.R., Ashby S.J., Collyer C.A., Harrop S.J., Hopwood J.J., and Guss J.M. Structure of a human lysosomal sulfatases. Structure 5 (1997) 277-289
14. Franco B., Meroni G., Parenti G., et al. A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy. Cell 81 (1995) 15-25
15. Lukatela G., Krauss N., Theis K., et al. Crystal structure of human arylsulfatase A: the aldehyde function and the metal ion at the active site suggest a novel mechanism for sulfate ester hydrolysis. Biochemistry 37 (1998) 3654-3664
16. Lam C.W., Chan A.O., Lai C.K., et al. A novel mutation, Y255X, of the ARSB gene in a Chinese family with mucopolysaccharidosis type VI. Chin Med J (Engl) 117 (2004) 1850-1852
17. Petry M.F., Nonemacher K., Sebben J.C., et al. Mucopolysaccharidosis type VI: identification of novel mutations on the arylsulphatase B gene in South American patients. J Inherit Metab Dis 28 (2005) 1027-1034
18. Dou W., Peng C., Zheng J., et al. Two novel mutations of the arylsulfatase B gene in a Chinese MPS VI child undergoing bone-marrow transplantation therapy. Clin Chim Acta 374 (2006) 171-172
19. Karageorgos L., Brooks D.A., Harmatz P., et al. Mutational analysis of mucopolysaccharidosis type VI patients undergoing a phase II trial of enzyme replacement therapy. Mol Genet Metab 90 (2007) 164-170
20. Karageorgos L., Brooks D.A., Pollard A., et al. Mutational analysis of 105 mucopolysaccharidosis type VI patients. Hum Mutat 28 (2007) 897-903
21. Garrido E., Chabas A., Coll M.J., et al. Identification of the molecular defects in Spanish and Argentinian mucopolysaccharidosis VI (Maroteaux-Lamy syndrome) patients, including 9 novel mutations. Mol Genet Metab 92 (2007) 122-130
22. McGovern M.M., Vine D.T., Haskins M.E., and Desnick R.J. An improved method for heterozygote identification in feline and human mucopolysaccharidosis VI, arylsulfatase-B deficiency. Enzyme 26 (1981) 206-210
23. Chang P.L., Rosa N.E., and Davidson R.G. Differential assay of arylsulfatase A and B activities: a sensitive method for cultured human cells. Anal Biochem 117 (1981) 382-389
24. Gibson G.J., Saccone G.T., Brooks D.A., Clements P.R., and Hopwood J.J. Human N-acetylgalactosamine-4-sulphate sulphatase. Purification, monoclonal antibody production and native and subunit Mr values. Biochem J 248 (1987) 755-764
25. Isbrandt D., Arlt G., Brooks D.A., Hopwood J.J., von Figura K., and Peters C. Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): six unique arylsultase B gene alleles causing variable disease phenotype. Am J Hum Genet 54 (1994) 454-463
26. Voskoboeva E.I.u., Krasnopol'skaia K.D., Peters K., and von Figura K. Identification of mutations in the arylsulfatase B gene in Russian mucopolysaccharidosis type VI patients. Genetika 36 (2000) 837-843
27. Yang C.F., Wu J.Y., Lin S.P., and Tsai F.J. Mucopolysaccharidosis type VI: report of two Taiwanese patients and identification of one novel mutation. J Formos Med Assoc 100 (2001) 820-823
28. Wu J.Y., Yang C.F., Lee C.C., Chang J.G., and Tsai F.J. A novel mutation (Q239R) identified in a Taiwan Chinese patient with type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome). Hum Mutat 15 (2000) 389-390
29. Schmidt B., Selmer T., Ingendoh A., and von Figura K. A novel amino acid modification in sulfatases that is defective in multiple sulfatase deficiency. Cell 82 (1995) 271-278
30. Balbach J., and Schmid F.X. Proline isomerization and its catalysis in protein folding. In: Pain R.H. (Ed). Mechanisms of protein folding (2000), Oxford University Press, New York 212-249
31. Litjens T., and Hopwood J.J. Mucopolysaccharidosis type VI: structural and clinical implications of mutations in N-acetylgalactosamine-4-sulfatase. Hum Mutat 18 (2001) 282-295
32. Karageorgos L., Harmatz P., Simon J., et al. Mutational analysis of mucopolysaccharidosis type VI patients undergoing a trial of enzyme replacement therapy. Hum Mutat 23 (2004) 229-233